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The adeno-associated virus type 2 (AAV) replication (Rep) proteins Rep78 and 68 (Rep78/68) exhibit a
number of biochemical activities required for AAV replication, including specific binding to a 22-bp region of
the terminal repeat, site-specific endonuclease activity, and helicase activity. Individual and clusters of charged
amino acids were converted to alanines in an effort to generate a collection of conditionally defective Rep78/68
proteins. Rep78 variants were expressed in human 293 cells and analyzed for their ability to mediate repli-
cation of recombinant AAV vectors at various temperatures. The biochemical activities of Rep variants were
further characterized in vitro by using Rep68 His-tagged proteins purified from bacteria. The results of these
analyses identified a temperature-sensitive (ts) Rep protein (D40,42,44A-78) that exhibited a delayed replica-
tion phenotype at 32°C, which exceeded wild-type activity by 48 h. Replication activity was reduced by more
than threefold at 37°C and was undetectable at 39°C. Stability of the Rep78 protein paralleled replication levels
at each temperature, further supporting a ts phenotype. Replication differences resulted in a 3-log-unit dif-
ference in virus yields between the permissive and nonpermissive temperatures (2.2 3 106 and 3 3 103,
respectively), demonstrating that this is a relatively tight mutant. In addition to the ts Rep mutant, we iden-
tified a nonconditional mutant with a reduced ability to support viral replication in vivo. Additional charac-
terization of this mutant demonstrated an Mg21-dependent phenotype that was specific to Rep endonuclease
activity and did not affect helicase activity. The two mutants described here are unique, in that Rep ts mutants
have not previously been described and the D412A Rep mutant represents the first mutant in which the helicase
and endonuclease functions can be distinguished biochemically. Further understanding of these mutants
should facilitate our understanding of AAV replication and integration, as well as provide novel strategies for
production of viral vectors.
Adeno-associated virus type 2 (AAV) is a nonpathogenic
human parvovirus that generally depends on coinfection with a
helper virus (adenovirus or herpesvirus) for efficient replica-
tion (reviewed in reference 10). The linear, single-stranded
DNA genome of AAV contains two open reading frames (rep
and cap) flanked by 145-bp inverted terminal repeats (ITRs)
(62). Replication of the AAV genome requires two viral com-
ponents, the ITR that serves as the origin of replication (26, 55,
57, 63) and the rep gene products (27, 57, 65). The rep gene
encodes four multifunctional proteins (27, 45, 65, 67) that are
expressed from two promoters at map units 5 (p5) and 19 (p19).
The larger Rep proteins transcribed from the p5 promoter
(Rep78 and Rep68 [Rep78/68]), are essentially identical except
for a unique carboxy terminus generated from unspliced (Rep78)
and spliced (Rep68) transcripts (62). Two smaller Rep proteins
(Rep52 and Rep40), transcribed from the p19 promoter, are
amino-terminal truncations of Rep78 and Rep68, respectively.
Several biochemical activities of Rep78/68 have been char-
acterized as being necessary for AAV replication. These in-
clude specific binding to the AAV ITR (4, 30, 59) and site-
specific endonuclease cleavage at the terminal resolution site
(trs) (31, 32, 58, 60). Rep78/68 also possess ATP-dependent
DNA-DNA helicase (31, 32) and DNA-RNA helicase (73) as
well as ATPase (73) activities. In addition to these activities,
which are required for replication, Rep78/68 also regulate
transcription from the viral promoters (8, 38, 39, 50, 66) and
have been shown to mediate viral targeted integration (6, 40,
51, 74). How Rep78/68 mediate these diverse activities in vivo
is still under investigation.
Mutant studies of the Rep proteins have indicated that the
activities of Rep can be divided into partially distinct functional
domains (Fig. 1A) that are spread throughout the protein
(14, 21, 43, 48, 68–71, 77). These include regions required
for binding to the ITR, a putative nucleoside triphosphate
(NTP) binding/ATPase domain, a nuclear localization domain,
and residues putatively required for nicking and helicase func-
tions. Rep proteins with mutations within the NTP binding/
ATPase domain that lacked trs endonuclease and viral repli-
cation were also defective for transactivation functions, sug-
gesting a need for further mutant analysis (43). Since most
mutants disrupt multiple Rep-mediated functions for the AAV
life cycle, the detailed characterization of distinct functions has
been difficult (21, 43, 48, 68–71, 77).
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The use of temperature-sensitive (ts) mutations has proven
to be an effective method for elucidating the essential functions
of viral proteins (11, 17, 46, 53). One approach for generating
ts mutants has been to utilize the charge-to-alanine mutagen-
esis strategy (7, 9, 18, 22, 49, 72). This approach has been utilized
by others to characterized AAV Rep functions (21, 68); how-
ever, none of these mutants were assayed for temperature
sensitivity. The rationale of this approach is that since most
charged residues are found on the protein surface, they are
expected to exert little effect on protein folding or stability (18,
19, 72), but could feasibly make a protein more thermosensi-
tive by disrupting electrostatic and H-bonding interactions (22).
In an attempt to generate ts Rep mutants, we used alanine
substitution to target a number of the functional domains crit-
ical for Rep-mediated activities. We describe the effects of
these mutations on Rep78-mediated replication of an ITR-
containing vector in adenovirus-infected human cells. We also
assayed several biochemical activities in vitro (i.e., ITR bind-
ing, trs endonuclease, and helicase) by using Rep68 His-tagged
fusion proteins expressed and purified from bacteria. From
these analyses, we identified three classes of mutants (Table 1).
Class I mutants were normal by in vivo replication and in vitro
biochemical analyses. A class II mutant (D40,42,44A-78) was ts
for expression and intracellular replication of AAV, resulting
in a 3-log-unit difference in viral titer between the permissive
and nonpermissive temperatures. In addition, a class III mu-
tant demonstrated a defect for replication, but protein stability
was wild type (wt) in nature. Further analysis of this mutant
demonstrated Mg21-dependent trs endonuclease activity,
which was unrelated to either DNA helicase or DNA binding
activity. This mutant Rep suggests that a specific interaction
between residue D412 and Mg21 is critical for endonuclease
activity. These data represent the first description of a ts AAV
Rep protein as well as the putative identification of an Mg21
binding pocket required for Rep-specific DNA nicking activity.
Further characterization of these mutants should prove useful
in studying AAV replication and integration and should pro-
vide new strategies for AAV vector-packaging cell lines.
MATERIALS AND METHODS
Plasmids and site-directed mutagenesis. All recombinant DNA manipulations
were performed by standard protocols (5). Unless otherwise noted, all enzymes
FIG. 1. AAV Rep78. (A) Schematic diagram of previously described functional domains (see text) within Rep78/68. Regions described as required for binding
(vertical stripes), nuclear localization (black box) (amino acids 483 to 519), oligomerization (gray box) (amino acids 466 to 476), and ATPase and helicase activities
(black line) (amino acids 334 to 421) and the unique region between Rep78 and Rep68 (horizontal stripes) (amino acids 537 to 621) are indicated. Overlapping DD35E
motifs are indicated as boxed residues corresponding to one motif at D368, D429, and E465 and as circled residues corresponding to a second motif at D412, D468,
and E504. (B) Eucaryotic expression cassette (pHIV-78) for generating Rep78 proteins. Protein expression is under control of the HIV LTR promoter and the poly(A)
signal from simian virus 40. The initiation codon (ATG) at p19 was changed to GGG to eliminate expression of Rep52 and Rep40, and the splice donor site was
modified (spl2) as described previously (74) to eliminate expression of Rep68. (C) Positions of point and clustered alanine mutations (open boxes) within the pHIV-78
expression plasmid. Amino acid changes are indicated by the nomenclature for each construct.
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were purchased from New England Biolabs and used according to supplier
recommendations. The mutants used in this study were originally generated in
the plasmid pHIV-78 (74). pHIV-78 (Fig. 1B) is a derivative of pHIV-Rep (2).
pHIV-Rep contains a wt rep gene and expresses all four Rep proteins from the
human immunodeficiency virus (HIV) long terminal repeat (LTR). To express
Rep78 in the absence of the other rep gene products, the splice site was modified
to prevent splicing and subsequent generation of the Rep68 and Rep40 proteins
(74). In addition, the initiation codon following the p19 promoter was changed to
GGG (13) to abrogate expression of Rep52. For simplicity, we have designated
the Rep78 protein expressed from pHIV-78 the wt Rep78 control, with the
recognition that the rep gene has been modified as described above.
Mutations were generated in the pHIV-78 construct by using a Vent polymer-
ase site-directed mutagenesis procedure essentially as described previously (12),
with an additional DpnI digestion step to remove the template DNA. DNA
sequencing (done at the University of North Carolina sequencing facility) con-
firmed point mutations. Regions immediately adjacent to the mutations were
subcloned back into the original pHIV-78 vector backbone and sequenced to
eliminate the possibility that additional mutations were introduced during PCR
mutagenesis.
Several of these mutations were also subcloned from pHIV-78 into an induc-
ible bacterial expression vector, pStump68 (78a), that expresses the Rep68 pro-
tein. The Rep68 proteins contain a C-terminal His6-tag (Rep68H6) for purifi-
cation of the recombinant proteins over nickel columns. Subcloned mutations
were confirmed by DNA sequencing, and inducible expression in Escherichia coli
was confirmed by Western blot analysis (data not shown).
The mutant D40,42,44A was also generated in the plasmid pIM45, which
contains the wt AAV genome without the terminal repeats (TRs) as previously
described (42). For clarity, these mutant Rep proteins, which are under the
control of the p5 promoter, will be designated mutD40,42,44A to distinguish
them from D40,42,44A-78 described in Fig. 1C. The mutD40,42,44A construct
was generated by site-directed mutagenesis as previously described (37) with the
oligonucleotide 59 CCG CCA GCT TCT GCC ATG GCT CTG AAT 39. The
pIM45 (wt) and mutD40,42,44A plasmids were used to produce virus from the
plasmid pTRUF5, which contains the green florescent protein (GFP) flanked by
the AAV TRs (79), to generate the virus rAAV-UF5 (GFP). An additional
recombinant AAV (rAAV) plasmid, pAB-11, that was used in these studies has
previously been described (24). Briefly, pAB-11 contains the b-galactosidase
gene under the control of the cytomegalovirus immediate-early promoter flanked
by the AAV ITRs.
Intracellular replication assays and viral replication time course. Subconflu-
ent 293 cells were cotransfected with mutant or wt pHIV-78 helper constructs
and the rAAV plasmid (pAB-11) at a 3:1 molar ratio, respectively, via Lipofectin
(Gibco/BRL) essentially as described in the supplier protocol. After 14 h, the
DNA-Lipofectin complexes were replaced with medium containing enough ad-
enovirus type 5 (dl309 [33]) to infect cells at a multiplicity of infection (MOI) of
5. When transfections were performed to evaluate ts activity of the mutants, all
reagents for transfection, including the cells and medium, were prewarmed and
incubated at the appropriate temperatures (32, 37, or 39°C) following transfec-
tion. At 48 h postinfection, low-molecular-weight DNA was extracted (28),
treated with RNase A, and digested extensively with DpnI to remove input
plasmid DNA. Southern blots were performed on digested DNA (5) and probed
with 32P-labeled b-galactosidase. Viral replication was determined by coinfecting
subconfluent human embryonic kidney (HEK) 293 cells with rAAV-UF5
(MOI 5 5) and adenovirus type 5 (MOI 5 5) and simultaneously transfecting
with the mutD40A,D42A,D44A or pIM45 plasmid. Hirt DNA was analyzed by
Southern blotting with a vector GFP-specific probe.
Production of rAAV GFP virus by using ts Rep plasmids. In order to produce
rAAV-UF5 virus, HEK 293 cells were cotransfected by the CaPO4 method as
previously described (61) with pTRUF5 (79), helper plasmid pXX6 to supply
adenovirus functions (75), and either wt pIM45 or mutD40,42,44A to supply Rep
functions. Following transfection, the cells were incubated for 48 h, harvested,
and subjected to three successive freeze-thaw cycles to liberate the virus. Incu-
bations were performed at 32, 37, and 39.5°C. The crude viral preparations
containing rAAV-UF5 were then titrated by counting GFP single-cell fluores-
cence.
ECL-Western blotting. ECL-Western blots analyses were performed on trans-
fected-cell lysates essentially as recommended by the supplier (Amersham), and
blots were probed with a monoclonal antibody raised against all four of the AAV
Rep proteins (29).
Purification of mutant and wt Rep68 His-tagged fusion proteins. His-tagged
Rep68 fusion proteins (Rep68H6) were purified from SG13009 cells (Qiagen) by
passage over nickel columns as previously described (78a) with minor modifica-
tions. Briefly, cleared cell extracts were incubated with Ni-nitrilotriacetic acid
agarose (Qiagen) for 3 to 4 h at 4°C, followed by elution with a 0.1 to 0.5 M
imidazole linear gradient. Eluted proteins were analyzed by sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis and silver staining (see Fig. 4)
according to the manufacturer’s protocol (Bio-Rad Silver Stain Plus). Protein
concentrations were determined with a bicinchoninic acid kit (Pierce) with bo-
vine serum albumin (BSA) as a standard and by direct comparison to known
amounts of BSA on a silver-stained SDS-polyacrylamide gel.
DNA substrates for in vitro biochemical assays. The AAV TR hairpin DNA
used in the majority of the biochemical assays was prepared by EcoRI di-
gestion of pDD (76), generating a 171-bp DNA fragment with D sequences
flanking either side of the TR (D9 A C9 C B9 B A9 D). The substrate was boiled
and snap cooled to form a hairpin with a double-stranded trs and then labeled
with [g-32P]ATP by using T4 polynucleotide kinase to generate the substrate,
32P-TR.
An AAV TR substrate with a single-stranded trs region (32P-TRss) was gen-
erated by digestion of psub201 (55) with XbaI and PuvII as previously described
(30) and labeled at the 59 end with T4 polynucleotide kinase.
The DNA substrate for the helicase assays was generated by annealing a
24-base primer (catalog no. 1224; New England Biolabs) to an M13 single-
stranded phage (catalog no. 70704; United States Biochemical) essentially as
described previously (31). The substrate (M13/24) was labeled with [a-32P]dATP
by using the Klenow fragment of DNA polymerase in the presence of 0.5 mM
dTTP and dGTP. For all substrates, the unincorporated nucleotides were re-
moved by passage over G25 spin columns (Boehringer Mannheim).
Electrophoretic mobility shift assays. Electrophoretic mobility shift assays
were performed essentially as previously described (44). Briefly, 0.01 to 0.02
pmol of 32P-TR was incubated with up to 9 ng (;0.15 pmol) of mutant or wt
Rep68H6 protein in 20-ml binding reaction mixtures (40 mM KCl, 10 mM
HEPES-KOH [pH 7.5], 0.2 mM dithiothreitol, 5% [vol/vol] glycerol, 0.5 mg of
BSA, and 1 mg of poly[dI-dC]) at 25°C for 30 min. Protein-DNA complexes were
resolved on 5% nondenaturing polyacrylamide gels and quantitated with a phos-
phorimager. Assays were performed in triplicate, and standard errors are indi-
cated in the figures.
trs endonuclease assays. Site-specific endonuclease activity was screened by trs
endonuclease assays as previously described (32), except where indicated other-
wise. Briefly, 20-ml reaction mixtures (25 mM HEPES-KOH [pH 7.5], 5 mM
MgCl2, 1 mM dithiothreitol, 0.4 mM ATP, 10 mg of BSA per ml) containing 0.005
to 0.02 pmol of 32P-TR (or 32P-TRss) and up to 9 ng (;0.15 pmol) of mutant or
wt Rep68H6 were incubated at 37°C for 60 min. Reaction products were treated
with protease K for 60 min, extracted with phenol-chloroform, precipitated, and
resolved on denaturing sequencing gels. The amount of product formed was
determined with a phosphorimager. Assays were performed in triplicate, and
standard errors are indicated in the figures.
Helicase assays. The helicase assays (31) were performed in the same reaction
buffer as for the trs endonuclease assay except where indicated otherwise. Briefly,
20-ml reaction mixtures containing 0.01 to 0.02 pmol of M13/24 and up to 9 ng
of mutant or wt Rep68H6 protein were incubated for 30 min at 37°C. Reactions
were terminated by addition of 10 ml of stop solution (0.5% SDS, 50 mM EDTA
[pH 7.5], 50% glycerol, 0.1% bromphenol blue, 0.1% xylene cyanole), resolved by
electrophoresis on a 5% nondenaturing polyacrylamide gel, and quantitated with
a phosphorimager. Assays were repeated a minimum of three times, and stan-
dard errors are indicated in the figures.
Structural modeling. Computational results were obtained by using software
programs from Molecular Simulations Inc. Dynamics calculations were per-
formed with the Discover Æ program, using the CFF91 forcefield; ab initio
calculations were done with the DMol program; and graphical displays were
printed out from the Cerius2 molecular modeling system.
TABLE 1. Summary of Rep protein mutations
Repa
Activity
Expression Replication Binding Nicking Helicase
Class I (wt)
Rep78 (wt) 1 1 1 1 1
E245A,D246A 1 1 NDb ND ND
K474A,D475A 1 1 ND ND ND
D519A,E521A 1 1 ND ND ND
I330C 1 1 ND ND ND
Y311F 1 1 1 1 1
E465A 1 1 1 1 1
D468A 1 1 1 1 1
E504A 1 1 1c 1c 1c
Class II (ts),
D40,42,44A
1/2d,e 1/2e 1 f 1 f ND
Class III, D412A 1 1/2 1 1g 1
a Mutant proteins are designated by the site(s) of their amino acid change(s).
b ND, not determined.
c Activity required 50-fold more protein than for the wt.
d 1/2, activity was less than 50% of wt.
e Activity was ts.
f Activity reduced relative to wt.
g Activity was sensitive to magnesium concentration.
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RESULTS
Generation of mutant and “wt” Rep78 constructs. In an
attempt to generate ts Rep mutants, we used a charge-to-
alanine substitution strategy (7, 9, 18) to target a number of the
putative functional domains critical for Rep-mediated activi-
ties (Fig. 1A). Site-directed mutations were generated in a
eucaryotic expression construct, pHIV-78 (74), that expresses
only the 78-kDa AAV Rep protein (Fig. 1B). In this construct,
the rep gene has been altered to prevent p19 protein expression
(ATG converted to GGG), as previously described (13). In
addition, the 59 splice site was inactivated so that only the
Rep78 protein initiated from the p5 promoter was expressed
(as described in Materials and Methods) (74). For simplic-
ity, we have designated the Rep78 protein expressed from
pHIV-78 the wt Rep78 control. By using intracellular expres-
sion, AAV-mediated replication, and in vitro biochemical as-
says, the mutants described in Fig. 1C were grouped into three
classes (class I, non-ts and normal; class II, ts for replication;
and class III, non-ts and defective for replication) (Table 1).
Intracellular expression of mutant and wt Rep78 proteins.
All of the mutant plasmids were sequenced and characterized
for the ability to express full-length Rep protein by transfection
in 293 cells. ts expression was determined by transfecting mu-
tant and wt pHIV-78 constructs into 293 cells at 32, 37, and
39°C, followed by Western blot analysis. A representative blot
of protein expression is shown in Fig. 2. Based on protein
expression at different temperatures, we designated two classes
of Rep mutants. The class I mutant proteins were expressed at
normal levels from the HIV LTR promoter, whereas the class
II mutant D40,42,44A-78 was present at levels below the de-
tection sensitivity of the ECL-Western blot analysis at 37 and
39°C (Fig. 2, lanes 8 and 9). Expression of this class II mutant
was confirmed at 37°C by overexposing Western blots (data not
shown) and by comparing lysates prepared from cells trans-
fected at 32°C (Fig. 2, lane 7). Detection of the class II mutant
protein at 32°C but not at 37°C suggested a ts Rep phenotype
(22).
Replication activities of mutant Rep78 proteins. The intra-
cellular functional activities of the Rep mutants (Fig. 3A) and
wt Rep78, wt Rep68, and a construct (wt Rep) expressing all
four Rep proteins (Fig. 3A, compare lanes 1, 14, and 15) were
determined by assaying the ability to mediate replication of an
rAAV plasmid (pAB-11) in the presence of adenovirus. The
replication activities of control plasmids expressing either wt
Rep78 or Rep68 appeared to be equivalent (Fig. 3A, compare
lanes 1 and 14). As expected, the construct expressing all four
Rep proteins (wt Rep) generated slightly more replicated
DNA in this assay (Fig. 3A, compare lanes 1 and 14 to 15).
Mutants that had less than 50% of wt Rep78 activity at 37°C
were considered to be defective for replication. Intracellular
replication assays were also performed at 32 and 39°C to de-
termine if the Rep mutants were ts in activity.
All of the class I mutants except D412A possessed replica-
tion activities that were similar to that of wt Rep78 under
physiological (Fig. 3A, lanes 2 to 5, 9, and 11 to 13) and
nonphysiological (data not shown) conditions. The class II
mutant, D40,42,44A-78, exceeded wt Rep78 replication at
32°C, but its activity was reduced over threefold at 37°C and
diminished to almost nondetectable levels at 39°C (Fig. 3A,
lanes 6 to 8). Both the temperature-dependent expression and
replication profiles for D40,42,44A-78 (Fig. 2, lanes 7 to 9, and
3A, lanes 6 to 8) indicate that this variant had a ts phenotype.
In addition to assaying AAV replication with the ts mutant
expressed from the HIV promoter cassette, the mutant was
also assayed in the context of all of the other AAV Rep pro-
teins (pIM45 helper construct, see Materials and Methods). In
these assays, replication was determined by Southern blotting
of Hirt extracts with an rAAV GFP vector (pTRUF5) for
replication and GFP transduction for virus yield (Fig. 3B and
Table 2, respectively). At 32°C, wt Rep demonstrated highest
levels of replication at 36 h, which diminished by 48 h (Fig. 3B).
At 32°C the ts mutant was delayed at 24 h, but replication
increased steadily and surpassed that of the wt at the 48-h time
point. At the nonpermissive temperature of 39°C, the ts mutant
was nonviable, while wt Rep demonstrated normal levels of
AAV replication at all time points (Fig. 3B). Virus yields for
the ts mutant (mutD40,42,44A) at 32, 37, and 39°C were 2.2 3
106, 3 3 104, and 3 3 103 transducing units/ml, respectively,
thus displaying over a 3-log-unit difference in titer between the
permissive and nonpermissive temperatures (Table 2). From
these analyses, charge-to-alanine mutant D40,42,44A-78 dis-
played all of the characteristics of a ts Rep protein.
After characterization of this ts mutant Rep protein, we
turned our analysis to other variants that displayed a replica-
tion phenotype but did not appear to be temperature sensitive.
The mutant D412A-78, which was originally identified as hav-
ing a class I mutant Rep phenotype based on protein expres-
sion (Fig. 2, lane 11), had AAV replication activity 5- to 10-fold
lower than that of wt Rep78 at all temperatures (Fig. 3A, lane
10, and data not shown). For this reason, D412A-78 was de-
FIG. 2. Immunoblot analysis of the various Rep78 proteins expressed from the HIV LTR in transiently transfected 293 cells. Mutant and wt pHIV-78 constructs
were transfected into 293 cells at 32, 37, and 39°C as described in Materials and Methods. A representative blot of protein expression is shown. With the exception of
D40,42,44A, all lysates were prepared from cells transfected at 37°C. Blots were hybridized with a monoclonal antibody that recognizes all four Rep proteins. All lanes
were loaded with 15 ml of cellular extract. p, proteins were detected after long-term exposure of blots.
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FIG. 3. Southern blot analysis of intracellular replication mediated by various Rep78 proteins. (A) Representative Southern blot of rAAV-LacZ (pAB-11)
replication mediated by mutant and wt Rep78 proteins expressed from the HIV LTR in adenovirus type 5-infected 293 cells. The replication assays shown were
performed at 37°C, except as indicated for D40,42,44A (lanes 6 to 8). The pHIV-78 and pAB-11 constructs were transfected at a 3:1 molar ratio as described in Materials
and Methods. Following transfection, the cells were incubated for 48 h with adenovirus type 5 (MOI of 5). At 48 h postinfection, Hirt DNA was extracted, digested
with DpnI, and analyzed by Southern blotting with a 32P-labeled probe specific for b-galactosidase sequences. Replicative monomer (M) and dimer (D) DNA forms
are indicated. p, replicated forms of pAB-11 were detected only after long-term exposure of blots. Rep68 was expressed from pHIV-68, a derivative of the pHIV-78
construct that has the rep gene intron removed as described previously (74). wt Rep is expressed from the pHIV-Rep construct, which expresses all four rep gene
products, as described in Materials and Methods. (B) Southern blot analysis of replication of an rAAV-UF5 virus (GFP) mediated by transfected wt pIM45 or
mutD40A,D42A,D44A pIM45 Rep expression plasmids. The pIM45 constructs express all four rep gene products (see Materials and Methods). Transfection infections
were performed at permissive (32°C) and nonpermissive (39.5°C) temperatures in adenovirus type 5-infected HEK 293 cells. Rep-containing plasmids (wt pIM45 or
mutD40,D42,D44A pIM45) were transfected into subconfluent HEK 293 cells and simultaneously coinfected with adenovirus type 5 (MOI of 5) and rAAV-UF5 (MOI
of 5). At various time points, Hirt DNA was extracted and analyzed by Southern blotting as described above with a 32P-labeled probe specific for GFP sequences.
No-plasmid lanes, cells were infected with adenovirus type 5 only; pIM45 (wt) lanes, cells were coinfected with adenovirus type 5 and rAAV-UF5 and transfected with
wt pIM45; mutD40,42,44A lanes, cells were coinfected with adenovirus type 5 and rAAV-UF5 and transfected with mutD40,D42,D44A,pIM45.
VOL. 73, 1999 ts AND Mg21-DEPENDENT AAV Rep VARIANTS 9437
fined separately as a class III mutant (normal protein levels but
decreased replication activity and not ts) and was further an-
alyzed.
In addition to the class II and III mutants characterized in
this replication assay, a high level of replication was mediated
by three class I mutant proteins, K474,D475A-78, Y311F-78,
and E465A-78 (Fig. 3A, lanes 3, 9, and 11, respectively). These
results are noteworthy considering that mutants with similar
mutations at these positions have previously been shown to be
negative for trs endonuclease activity when measured in vitro in
the context of the maltose-binding protein (MBP)–Rep68D
fusion protein (21, 69).
In vitro expression and purification of mutant Rep proteins.
In an effort to further characterize the non-ts Rep mutants
initially evaluated in the intracellular replication study, several
mutant constructs (Y311F, D412A, E465A, D468A, and
E504A) were subcloned into the bacterial expression vector
pStump68 (78a) for purification and characterized of Rep-
specific biochemical activities. The pStump68 construct al-
lowed for high-level expression and purification of Rep68 pro-
teins from E. coli via a His6-tag fusion. Overexpression and
purification from this vector enabled us to compare the activ-
ities of the mutant Rep proteins to well-established biochem-
ical activities previously assigned for wt Rep68 (30–32). Silver
stained SDS-polyacrylamide gels (Fig. 4) and Western blot
analysis (data not shown) demonstrated that the His6-tagged
proteins were purified to greater than 95% homogeneity. With
the exception of mutant E504A-68, the Rep mutants expressed
similar amounts of stable Rep68 protein (Fig. 4). Mutant
E504A-68 required 50 times more total protein when assayed
under these conditions and appeared to have a pronounced
profile of breakdown products that were similar to those of
Rep68 purified from baculovirus (Fig. 4, lanes 6 and 7). This
was in contrast to its expression in 293 cells, which appeared to
be normal (Fig. 2, lane 14). These two contradicting data
suggest that this mutant may be unstable in the context of the
His-tagged fusion protein. While this result exemplifies the
concern of modifying Rep for E. coli expression, all other con-
structs generated identical protein profiles both in vivo and in
vitro, supporting further analysis of their biochemical activities.
Interaction of Rep68H6 proteins with the AAV TR. Standard
mobility shift assays were used to compare the specific binding
of mutant and wt Rep68H6 proteins to the hairpin TR sub-
strate (32P-TR). Binding titration profiles performed with each
class of mutant protein were similar to that for wt Rep68H6
(data not shown). A representative binding assay with a pro-
tein-to-DNA molar ratio of ;10:1 demonstrated that all of the
His-tagged E. coli-produced proteins bound specifically to 32P-
TR (Fig. 5A). Specific binding to the TR suggested that neither
the point mutations nor the addition of the His6-tag signifi-
cantly altered the DNA binding activities of these Rep68 pro-
teins. However, as observed in the silver stain analysis, approx-
imately 50-fold more total protein was used in the binding
assays for E504A-68 relative to wt Rep68H6.
Effect of mutations on Rep68H6 trs endonuclease activity.
Site-specific and strand-specific endonuclease cleavage of the
AAV TR by Rep78/68 is an essential part of AAV replication
(47). All of the mutants examined specifically nicked the TR at
the trs, generating the proper-sized product (Fig. 5B). In the
nicking assay shown (Fig. 5B), a protein-to-DNA molar ratio
of ;10:1 was used for all of the mutants except E504A-68,
which required ;50-fold more total protein to obtain the same
level of cleaved product.
Also of interest was the wt level of cleavage observed with
the mutants Y311F-68 and D465A-68 (Fig. 5B). From previ-
ously published studies, Rep proteins with mutations at these
positions were not expected to display nicking activity (69). We
suspect that the discrepancy between our analysis and others
concerning in vitro biochemical activities (69) are related to
the MBP-Rep68 fusion protein. With the exception of mutant
E504A-68, we did not observe an influence on Rep activity in
the context of the Rep68H6 protein. In addition, these same
mutants when expressed from the HIV LTR promoter cassette
in vivo without the His modification all displayed AAV repli-
cation activity, supporting the in vitro biochemical analyses.
Effect of mutations on Rep68H6 helicase activity. Under the
reaction conditions used in these assays (;10:1 protein-to-
DNA molar ratio), all of the Rep68H6 mutants examined
exhibited helicase activity (Fig. 5C).
The retention of nicking and helicase activities by D412A-68
was somewhat surprising, considering that this mutant was
notably defective in the intracellular replication assay (Fig. 3,
lane 10). In an effort to assign a phenotype to the D412A
mutation, more comprehensive biochemical analyses compar-
ing the activity of D412A-68 to that of Rep68H6 were con-
ducted.
Affinity of D412A-68 versus Rep68H6 for the hairpin TR. In
the assays described above, a difference in binding between
D412A-68 and wt Rep68H6 was not detected. This suggested
that the replication defect observed with D412A-78 in the
intracellular assays was not due simply to an inability to inter-
act efficiently with the viral TR. While we used 500-fold less
FIG. 4. SDS-polyacrylamide gel electrophoresis–silver stain analysis of puri-
fied mutant and wt Rep68H6 proteins overexpressed in E. coli. Proteins were
expressed from the inducible expression cassette pStump68 and purified via a
His6 tag by passage over nickel-agarose columns (Qiagen) as described in Ma-
terials and Methods. The position of full-length Rep68H6 is indicated. The same
amount of protein was loaded in each lane, except for E504A-68, which required
50-fold more protein to achieve the same level of full-length protein. The lower-
molecular-weight products visible in the gel (especially in lanes 6 and 7) were
mostly degradation products as indicated by Western blot analysis (data not
shown). Rep68* was expressed in a baculovirus system and purified as described
previously (30).
TABLE 2. Yield of rAAV-UF5 (GFP) virus
Rep
Yield (transducing units/ml)a at:
32°C 37°C 39.5°C
pIM45 (wtb) 9.4 3 105 1.7 3 106 6.8 3 105
mutD40,42,44Ac 2.2 3 106 3.0 3 104 3.0 3 103
a See text.
b All four rep gene products are expressed.
c Mutations were generated in the pIM45 vector.
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Rep protein than used in other studies (69), we still had excess
protein relative to the TR concentration, potentially masking
any subtle differences in binding efficiency. In order to deter-
mine the concentrations of D412A-68 and wt Rep68H6 re-
quired to bind 50% of the substrate (KD), binding assays were
performed as a function of protein concentration. The appar-
ent KD values were determined from plots of the percentage of
TR bound versus protein concentration (Fig. 6A). The appar-
ent KD values for wt Rep68H6 and D412A-68 for the TR were
essentially the same, at about ;3 nM (Fig. 6A). These values,
which were derived from assays performed in triplicate, were
also within the nanomolar range previously described for bac-
ulovirus-purified Rep68 binding to a hairpin TR substrate (44).
Titration of trs endonuclease and helicase activities. In an
effort to identify gross biological differences between the mu-
tant and wt Rep (Fig. 5B and C), protein levels were in excess
relative to the respective DNA substrates. In the following
assays, the efficiency of D412A-68 compared to that of wt
Rep68H6 in the trs endonuclease and helicase activities was
determined as a function of protein concentration (Fig. 6B and
C, respectively). In the nicking assay comparisons, nearly
threefold more D412A-68 protein was required to nick 50% of
the substrate, and about 25% less substrate was cleaved overall
relative to that with wt Rep68H6 (Fig. 6B). In contrast, no
significant differences were observed between the efficiencies
of D412A and wt Rep68H6 in the helicase assay (Fig. 6C).
Effect of magnesium concentration on Rep68 functions. Pre-
vious studies have shown that the endonuclease activity of
Rep68 requires magnesium (Mg21) (31). In the nicking reac-
tions described above, the Mg21 concentration [Mg21] was
held constant at 5 mM, which is approximately 10-fold greater
than would be present in the intracellular environment (1).
Under such conditions, if an interaction between Mg21 and
Rep68 was necessary to form an active transition state for
nicking, a difference in binding affinity for Mg21 might go
unnoticed. Excess Mg21 in the nicking reactions should shift
the equilibrium in favor of binding, therefore potentially mask-
ing a mutant protein phenotype. For this reason, nicking re-
actions were performed under conditions of low [Mg21] (Fig.
7A). Neither of the proteins was very efficient at nicking the
TR when the [Mg21] was ,500 mM. However, wt Rep68H6
activity increased linearly with [Mg21] and cleaved about 14-
fold more substrate at 250 mM Mg21. In contrast, we could not
detect any cleaved substrate with D412A-68 at ,200 mM
Mg21. The sensitivity to [Mg21] with D412A-68 suggested that
this mutant had a diminished ability to bind Mg21 and that an
FIG. 5. In vitro biochemical analyses of His-tagged Rep68 proteins. (A) Gel
mobility shift assay of mutant and wt Rep68H6 proteins expressed in E. coli.
Standard binding reaction mixtures contained 0.5 nM 32P-labeled AAV TR
hairpin DNA (32P-TR) and 6 nM purified Rep68 protein containing the indi-
cated mutation. Reactions were carried out in standard binding reaction buffer
(see Materials and Methods) at 25°C for 30 min, and products were resolved on
nondenaturing 5% polyacrylamide gels. Mutant and Rep68H6 (B) proteins were
purified by one passage over nickel columns (batch) while Rep68H6 (M) was
further purified by passage over a Mono Q column. (B) Terminal resolution by
His-tagged Rep68 proteins. Standard trs endonuclease assays contained 0.5 nM
32P-TR substrate and 5 nM His-tagged protein. Nicking reactions were per-
formed in standard nicking buffer (see Materials and Methods) for 60 min at
37°C, followed by protease K digestion and phenol-chloroform extraction, and
products were resolved on denaturing polyacrylamide sequencing gels. Substrate
(S) and cleavage products (P) are indicated. (C) Standard helicase reactions were
performed at 37°C for 60 min in nicking buffer containing 0.5 nM substrate
(M13/24) and 6 nM protein, and products were resolved on 5% nondenaturing
polyacrylamide gels. Substrate (S) and released product (P) are indicated.
Boiled, positive control. In all of the assays described for Fig. 5, E504A-68
required 50-fold more protein to achieve the level of activity shown.
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interaction between Mg21 and D412 was necessary for efficient
trs endonuclease activity in vitro.
In addition to requiring Mg21 for endonuclease activity, Rep
also requires the ATP-dependent helicase activity to nick the
viral TR (59). The Rep helicase activity was suggested to be
necessary to unwind the double-stranded TR in order to ex-
pose the trs (59). This function also requires Mg21 (31). Thus,
the sensitivity to [Mg21] in the above-described nicking assays
could also reflect an impairment of helicase activity. To ad-
dress this possibility, we titrated [Mg21] levels in a Rep-de-
pendent helicase assay previously described (31). From this
analysis, D412A-68 and wt Rep68H6 had similar Mg21 require-
ments in the helicase assay (Fig. 7B).
To further demonstrate that the Mg21 dependence of the
class III mutant D412A was related to Rep’s trs endonuclease
activity and not related to helicase function, we performed TR
nicking assays with a modified TR substrate. Previously, Sny-
der et al. (59) generated a TR substrate with the nicking site
(trs) existing as a single-stranded DNA. Those authors were
able to demonstrate wt Rep nicking activity in the absence of
ATP, suggesting that the helicase function to expose the nick-
ing site was not required. We performed identical nicking as-
says with the D412A mutant Rep and demonstrated that the
amount of cleaved product with this single-stranded substrate
(32P-TRss) was also sensitive to Mg21 levels (Fig. 7C). This
data supports the role of Rep amino acid D412 in Mg21 bind-
ing and suggests that this interaction is important in AAV trs
endonuclease activity.
DISCUSSION
In the absence of a crystal structure, assignment of structure-
function activities to the AAV Rep proteins has relied on
mutational analysis studies. Mutational analysis of the AAV
Rep proteins has indicated that Rep-mediated activities can be
attributed to somewhat distinct functional domains (Fig. 1A)
(14, 21, 43, 48, 68–71, 77). However, in these mutational stud-
ies, multiple effects were observed due to the disruption of
more than one Rep biological activity. In this study we used a
charge-to-alanine mutagenesis strategy (7, 9, 18) to target a
number of Rep78/68 functional domains in an attempt to gen-
erate a collection of ts mutants (22, 49, 72). We describe the
effects of these mutations on Rep78-mediated replication of an
rAAV vector in adenovirus-infected 293 cells and on in vitro
biochemical assays with purified Rep68 His-tagged fusion pro-
teins expressed in bacteria. Using this alanine substitution
strategy, we generated mutants that were grouped into three
classes based on their functional activities (Table 1). These
included class I mutants (E245A,D246A, Y311F, I330C,
E465A, D468A, K474A,D475A, and E504A), which retained
normal activity; a class II mutant (D40,42,44A), which was ts
for replication; and a class III mutant (D412A), which was not
ts but was defective for replication and more [Mg21] depen-
dent for in vitro endonuclease activity.
The expression and replication activity of the mutant Rep
proteins relative to those of a wt Rep78 protein in 293 cells at
permissive and nonpermissive temperatures were character-
ized. Similar to results of previous alanine mutagenesis studies
(9), the majority of the mutants (class I and III) were stably
expressed at levels similar to those of wt protein (wt Rep78)
(Fig. 2). The class I mutants also exhibited wt activities in the
intracellular replication assays (Fig. 3A) and in the biochemi-
FIG. 6. Binding, trs endonuclease, and helicase activities of D412A-68 and
Rep68H6 as a function of protein concentration. (A) Standard binding reactions
were performed as described for Fig. 5A and carried out in triplicate with 1 nM
substrate (32P-TR) and the indicated concentration of each protein. (B) Stan-
dard nicking reactions were performed as described for Fig. 5B and carried out
in triplicate with 1 nM 32P-TR substrate and the indicated concentration of each
protein. (C) Standard helicase reactions were performed as described for Fig. 5C
and carried out four times in nicking buffer containing 1 nM substrate (M13/24)
and the indicated concentration of protein.
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cal assays in vitro (Fig. 5). Interestingly, we determined that
three of the mutants (Y311F, E465A, and K474,D475A)
grouped within this class were active, whereas similar mu-
tants have previously been shown to lack endonuclease activity
in the context of the MBP-Rep68 fusion protein (21, 69). The
discrepancy between these observations suggests a need for
concern when evaluating only in vitro Rep activity by using
fusion proteins. For this reason, we first assayed all of the
mutants in intracellular replication assays in the context of the
Rep78 protein (Fig. 3A) and supported these analyses by in
vitro studies. Of the mutant Rep proteins that we analyzed in
vitro, only mutant E504A displayed protein stability character-
istics contrary to those seen in in vivo analysis (compare Fig. 2,
lane 14, to Fig. 4, lane 6). Since completion of our study, Davis
et al. (21) generated an MBP Rep fusion protein with muta-
tions identical to that of the ts mutant we describe here. In
these in vitro studies, D40,42,44–MBP-68 does not bind or nick
the TR, contrary to our in vitro and in vivo results.
While steady-state protein levels for the class II ts mutant
(D40,42,44A) at 37°C were generally below the sensitivity lim-
its of the ECL-Western blot analyses (Fig. 2), expression was
shown to be at wt levels at 32°C. This class II mutant was also
notably defective for replication under physiological conditions
(Fig. 3A). D40,42,44A-78 mediated replication much more
efficiently at 32°C (;3-fold) than at 37°C and was essentially
inactive at 39°C. The instability of the class II mutant Rep
protein (D40,42,44A) corroborated ts replication data (Fig. 3),
allowing us to assign a ts replication phenotype. When this
mutant was assayed in the context of all four Rep proteins
(pIM45 plasmid), its activity was similar to that seen with the
HIV construct (Fig. 3B), although the stability of the pIM45
mutant Rep was not characterized. In addition, a 3-log-unit
difference in titer was observed when permissive and nonper-
missive temperatures were compared (Table 2). All of these
analyses support Rep mutant D40,42,44A-78 having a ts phe-
notype. The 3-log-unit difference in Rep function demon-
strates that this is a tight mutant and should be useful in fur-
ther analysis of Rep function.
Mg21 binding mutant. The mutant D412A was categorized
in a separate class (class III), since it was expressed at wt levels
(class I) but did not exhibit a temperature-dependent pheno-
type (class II). However, this mutant was markedly reduced in
its ability to mediate replication in the intracellular assays (Fig.
3A). When the biochemical activities of D412A were analyzed
in the context of the Rep68 His-tagged fusion protein, this
mutant bound efficiently to the TR (Fig. 6A) but had a reduced
level of endonuclease activity relative to wt Rep68H6 (Fig.
6B). The reduced nicking activity of D412A-68 was shown with
both single-stranded and double-stranded substrates and ap-
peared to be more Mg21 dependent for activity (Fig. 7A and
C). While Mg21 is also required for Rep ATP-dependent he-
licase activity, we did not see an [Mg21]-dependent phenotype
for the D412A mutation in helicase assays (Fig. 7B). The
biochemical assays that we have described support that the
Rep mutant D412A has diminished ability to interact with
Mg21 and that an interaction between D412 and Mg21 is
necessary for efficient trs endonuclease activity. These results
were reproducible with multiple Rep protein extracts, further
supporting that the active DNA cleavage site of Rep78/68
consists, at least in part, of D412 and Mg21.
FIG. 7. trs endonuclease and helicase activities of D412A-68 and Rep68H6
as a function of magnesium concentration. (A) Endonuclease reactions were
performed as described for Fig. 5B and carried out in triplicate. Nicking buffer
contained 1 nM substrate (32P-TR) with a double-stranded (ds) nicking site (trs),
3 nM protein, and the indicated [Mg21]. (B) Helicase assays were performed as
described for Fig. 5C and carried out in triplicate in nicking buffer that contained
1 nM helicase substrate (M13/24), 3 nM protein, and the indicated [Mg21]. (C)
Nicking reactions were performed as described for Fig. 5B and carried out in
triplicate. Nicking buffer contained 1 nM substrate (32P-TRss) with a single-
stranded (ss) nicking site (trs), 3 nM protein, and the indicated [Mg21].
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FIG. 8. Structural analysis of the magnesium binding pocket and catalytic active site for nuclease activity. (A) Crystal structure of the active site for the HIV
integrase, INT (23). Residues critical for magnesium binding and nuclease activity are indicated; beta strands are colored blue, and helices are colored red. (B)
Theoretical structural model of the Rep78/68 active site for nicking. Residues 391 to 534 were used to generate a theoretical model of the magnesium binding domain
of Rep by using secondary structural predictions (64, 79a) and the computer software programs from Molecular Simulations Inc. (see Materials and Methods). Residues
potentially critical for magnesium binding and Rep nuclease activity based on this model are shown.
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Nearly all endonucleases employ Mg21 or some divalent
cation as part of their catalytic mechanism. Since the nicking
activity of Rep78/68 is required for replication of AAV, a
decreased affinity for Mg21 could effectively explain the intra-
cellular replication defect observed with D412A-78. An inabil-
ity to efficiently interact with Mg21 would especially inhibit
intracellular activity, where limited Mg21 reserves (0.5 mM)
must be utilized by all other proteins present in the cellular
milieu. For instance, the binding affinity of the restriction en-
donuclease EcoRV for Mg21 is at physiological levels, and thus
any disruption in Mg21 binding results in loss of function (56).
Supporting this conclusion, we have shown that increasing the
intracellular Mg21 levels (23a) can increase the replication
activity of D412A-78 in an Mg21-dependent manner. While
the data presented in this study implies a role for Mg21, the
overall phenotype of this mutant may be in part related to
other defects (e.g., an inability to associate with host factors,
form stable Rep-Rep complexes, migrate efficiently to the nu-
cleus, or be sequestered in AAV replication centers). Further
analysis will help elucidate the complete role of the Mg21-
dependent mutant phenotype and AAV replication in vivo.
DD35E motif. The D412 mutation maps to a region of
Rep78/68 that contains a cluster of acidic amino acid residues
that have the potential to form overlapping DD35E motifs
(Fig. 1). The acidic amino acids of the DD35E motif have been
shown to form an Mg21 binding pocket that is critical for the
nicking and strand transfer reactions of bacterial transposases
and retroviral integrases (16, 36, 52). One might speculate that
the decreased affinity for Mg21 with D412A was consistent
with the partial disruption of a similar putative Mg21 binding
domain. Based on this assumption, mutations at any of the
conserved DD35E motif residues should result in the loss of
some in vitro function as previously described (35, 36).
Rep78/68 mutants generated within this putative DD35E motif
(D468A and E504A) were identified as class I mutants with wt
phenotypes, suggesting that these residues are not critical for
catalytic function. However, this does not rule out the possi-
bility that the second putative DD35E motif within Rep78/68
was involved in the coordination of the active-site Mg21 ion(s).
We also introduced a mutation at E465A within this second
putative DD35E motif (at residues D368, D429, and E465)
(71) to test the relevance of this DD35E cluster. The activity of
this mutant was also similar to that of wt Rep78/68.
Based on this analysis, these two distinct motifs may be
unrelated to any function in AAV Rep. However, the presence
of overlapping DD35E motifs raised the interesting question of
whether these acidic acid clusters were capable of cooperating
to coordinate Mg21, thus compensating for mutations at
E465A, D468A, and/or E504A. To test this possibility we have
subsequently generated a double mutant (D412A,E465A-78)
that contains a mutation in each of the two putative DD35E
Mg21 binding pockets described above (23a). The phenotype
of this double mutant was negative for AAV replication (23a).
Continued studies are under way to determine the role, if any,
of the two overlapping DD35E motifs in the AAV Rep pro-
teins (23a).
Mg21 binding pocket. One of the reasons that we were
originally intrigued by the DD35E motif was that Rep medi-
ates targeted integration by an as-yet-unknown mechanism.
Also, the DD35E motif is highly conserved among enzymes
that mediate transposition and integration (16). A number of
crystal structures have been solved for various Mg21-depen-
dent nucleases, such as HIV integrase (23, 41) and Mu trans-
posase (54), which utilize the DD35E motif, as well as E. coli
RNase H (34), HIV RNase H (20), and the E. coli resolvase
RuvC (3). Genetic and crystallography studies have demon-
strated that the catalytic cores of these enzymes consist of a
cluster of acidic residues that interact directly with Mg. While
the primary sequences of these proteins are quite diverse, the
overall secondary and tertiary structures of these enzymes are
strikingly similar (25, 78). As shown with HIV integrase (Fig.
8A), The active domains of these structures consist of five
central beta strands flanked by a various number of alpha
helices (23, 41).
Using the data from secondary structural predictions (64,
64a), and homology-modeling software programs from Molec-
ular Simulations Inc., we generated a theoretical structure for
the active site of Rep78/68 (Fig. 8B) that was similar to those
of HIV integrase and RuvC. In this theoretical model, residue
D412 is positioned within the central beta strands of the pu-
tative catalytic core (Fig. 8B). In addition, other amino acids
that would potentially be critical in this model are identified
(Fig. 8B). These amino acids are also highly conserved among
the AAV serotypes (15). Studies to support or dismiss the
theoretical model described here for a Rep-dependent Mg21
binding pocket are under way. However, it should be noted
that in addition to this motif, AAV has a number of domains
that are similar to published structural motifs (i.e., Walker A
and B domain for NTP binding and helicase activities, DD35E
and HxH metal binding domains, and the YXXXY motif uti-
lized by fX174 for rolling-circle replication). All of these pre-
dictions are supported by sequence homology or genetic stud-
ies and still await crystal analysis of Rep for final confirmation.
The results of this study in conjunction with those of studies
examining the frequency at which D412A and the other mu-
tants, especially tsD40,42,44A-78, mediate targeted integration
should also help clarify the relationship between the replica-
tion and integration activities mediate by Rep. An Mg21 de-
pendence for efficient targeted integration with the D412A
mutant would also provide valuable insight into the mechanism
of this Rep-mediated activity. Finally, the availability of the ts
and non-ts AAV Rep proteins described in this study should
provide novel approaches for generating rAAV packaging sys-
tems, including packaging cell lines, adenovirus and/or herpes
simplex virus helper viruses, and in vitro packaging systems.
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